# Peking University Shenzhen Hospital

Organization · id `cardio:org-peking-university-shenzhen-hospital` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 03kkjyb15](<https://ror.org/03kkjyb15>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 03kkjyb15 by an exact name.

## The registry's words

- Sponsor name: Peking University Shenzhen Hospital
- Sponsor class: OTHER
- ROR name: Peking University Shenzhen Hospital

## Connected pages

- Sponsors: Effects of Different Early Intensive Therapies on Long-term β-cell Function (`cardio:ct-nct01471808`)
- Sponsors: Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic Therapy (`cardio:ct-nct03700801`)
- Sponsors: Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis (`cardio:ct-nct06447701`)

## Provenance

Content hash: 9259faae9dde510bc83e087a0bb6dff78b2461ba45f4914b975ee2f40f36186d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
